ISA 100.11a Networked Control System Based on Link Stability

Wireless networked control systems (WNCSs) must ensure that control systems are stable, robust and capable of minimizing the effects of disturbances. Due to the need for a stable and secure WNCS, critical wireless network variables must be taken into account in the design. As wireless networks are composed of several links, factors that indicate the performances of these links can be used to evaluate the communication system in the WNCS. This work presents a wireless network control system composed of ISA 100.11a sensors, a network manager, a controller and a wired actuator. The system controls the liquid level in the tank of the coupled tank system. In order to assess the influence of the sensor link failure on the control loop, the controller calculates the link stability and chooses an alternative link in case of instability in the current link. Preliminary tests of WNCS performance were performed to determine the minimum stability value of the link that generates an error in the control loop. Finally, the tests of the control system based on link stability obtained excellent results. Even with disturbances in the network links, the control system error remained below the threshold.

Inhibition of gastric and pancreatic secretions by cerebroventricular injections of gastrin-releasing peptide and bombesin in rats

It has been suggested that mammalian gastrin-releasing peptide (GRP) and bombesin (BBS) might inhibit gastric secretion by a central nervous system action. The present investigations were intended to define the gastric effect and to look for an effect on the exocrine pancreas. Wistar male rats were provided with a chronic cannula allowing cerebroventricular injections in the 3rd ventricle, and with chronic gastric and/or pancreatic fistulas allowing the collection of gastric and/or pancreatic secretions in conscious animals. Both basal secretions were studied. Gastric secretion was stimulated with a 75 mg/kg s.c. injection of 2-deoxyglucose (2-dGlc). The dose range of bombesin was 0.01-1 microgram (6-600 pmol) and GRP was 0.01-10 microgram/rat (3.5 pmol to 3.5 nmol). A significant dose related decrease of basal gastric secretion was observed with the two peptides. The gastric acid response to 2-dGlc was inhibited by both peptides in a dose-related fashion and the reduction of gastric acid output mainly resulted from a decrease in the volume of gastric juice. The exocrine pancreatic secretion was also decreased by 30-55% after GRP but the BBS inhibitory effect was poorly dose-related. No significant difference was found after removal of gastric secretion, indicating that most of the pancreatic inhibition was independent of gastric secretion.